Journal profile · Medicine-Oncology
Precision Radiation Oncology
ISSN 2398-7324 · Wiley · Australia
Precision Radiation Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); fully open access; APC about USD 2,500; median 129 days to acceptance (95 articles, last 24 months); acceptance rate 30% (journal website); 48 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Precision Radiation Oncology is published by Wiley and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Radiation Therapy and Dosimetry and Effects of Radiation Exposure, together about 34.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Precision Radiation Oncology (PRO, which is also called BLUE JOURNAL) aims to offer a forum for collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. The editors encourage contributions relevant to radiodiagnosis, radiotherapy, radiation physics, radiation biology, interventional therapy, and nuclear medicine in cancer, including basic cancer research, as well as translational and clinical cancer research. Precision Radiation Oncology is supported by Sino-American Network for Therapeutic Radiology and Oncology(SANTRO), and Chinese Anti-Cancer Association(CA-CA) . Precision Radiation Oncology is an open access journal. Manuscripts accepted for publication will be published as open access articles, immediately free to read, download and share. Authors or their funder will be not required to pay an article publication charge at present. The journal publishes a range of article types including: Original articles, Clinical Guidelines, Consensus, Commentaries, Editorials, Reviews, Meeting reports, Case reports, Brief Reports, Research letters, Letters to the Editor, and Perspective.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Jinming YuPublisher website
Editorial board by country: 175 in mainland China (about 83%); most named Mainland China 175, United States 30, Australia 2, Hong Kong, China 1, Japan 1 (211 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy19.3%
- Radiation Therapy and DosimetryMedicine9%
- Effects of Radiation ExposureMedicine6.3%
- Lung Cancer Diagnosis and TreatmentMedicine6.2%
- Radiomics and Machine Learning in Medical ImagingMedicine4.9%
- Head and Neck Cancer StudiesMedicine4.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.8%
- Human auditory perception and evaluationEngineering3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.6Publisher website ·
- Impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher)
- 4.8Publisher website ·
- CiteScore (publisher) 2025
- 4.8Publisher website ·
- SJR 2026-06
- 0.75LetPub ·
- SNIP 2026-06
- 1.42LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 41OpenAlex ·
- 2-year mean citedness
- 3.2OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 35LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 38Publisher website ·
- Downloads per year (publisher) 2025
- 92,885Publisher website ·
Articles by year OpenAlex count · 415 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 56 | 56 | 10 |
| 2025 | 48 | 48 | 153 |
| 2024 | 36 | 36 | 285 |
| 2023 | 38 | 38 | 200 |
| 2022 | 42 | 42 | 398 |
| 2021 | 39 | 39 | 150 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
129 daysMedian, submission to acceptance · P25–P75 79 days – 183 days
- Acceptance to online
- median 37 days (95 articles)
- Submission to online
- median 187 days
- Sample
- 95 articles with submission and acceptance dates (99 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Acceptance rate (publisher)
- 30%Publisher website ·
- Acceptance rate (publisher) 2025
- 30%Publisher website ·
- Submission to first decision
- 28 daysPublisher website ·
- Submission to first decision 2025
- 28 daysPublisher website ·
- Submission to acceptance 2025
- 134 daysPublisher website ·
- Acceptance to publication 2025
- 31 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,500 / GBP 2,080 / EUR 2,400 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| LetPub | USD 2,650 / GBP 1,750 / EUR 2,200 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
Article types accepted8, with length limits
- brief reportd paper for initial consideration. (10) Brief Reports Word limit: 1500 words including abstract but excluding references, tables and figmain text ≤ 1,500 words
- case reportce or tone of a letter or response. (8) Case Reports Word limit: 1000 words maximum including abstract but excluding references, tablesmain text ≤ 1,000 words
- commentaryed paper for initial consideration. (5) Commentaries Word limit: 1500 words maximum excluding references. Abstract: not required. Refermain text ≤ 1,500 words
- editorialnced by the guidelines / consensus. (4) Editorials Word Limit: 1500 words maximum. Abstract: not required. References: 5 maximum. Desmain text ≤ 1,500 words
- original articlepublisher. 4. MANUSCRIPT CATEGORIES (1) Original Articles Word limit: 4000 words maximum including abstract but excluding references, tablesmain text ≤ 4,000 words
- original articlesOriginal ArticlesWord limit: 4000 words maximum including abstract but excluding references, tables and figures. Abstract: 250 words maximum, with sub-headers. …Length not stated
- perspectiveons will undergo full peer review. (11) Perspectives Word limit: 1000 words excluding references, tables and figures. Abstract: not reqmain text ≤ 1,000 words
- reviewbasic or clinical science. (2) Invited Reviews Word limit: 5000 words maximum including abstract but excluding references, tablesmain text ≤ 5,000 words
Policy excerpts from the journal's websiteData availability, Publication ethics, Open access, Plagiarism, Trial registration / reporting guidelines
- Data availability
Expects data sharing for manuscripts submitted after June 15th, 2024. Model summary
This journal expects data sharing for manuscripts submitted after June 15th, 2024.
Source ↗Publisher website ·- Publication ethics 3. ETHICAL CONSIDERATIONS
Follows COPE core practices and handles research and publication misconduct accordingly. Model summary
The journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. Please review the Best Practice Guidelines policies on human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines.
Source ↗Publisher website ·- Open access 7. OPEN ACCESS LICENSING
Precision Radiation Oncology is an Open Access journal. If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
Source ↗Publisher website ·- Plagiarism
Uses iThenticate's CrossCheck software to detect overlapping and similar text in submitted manuscripts. Model summary
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trials must be prospectively registered in a publicly accessible database; registration numbers included in papers reporting results. Model summary
We require that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- Australia
- Language
- English
- ISSN
- 2398-7324
- Society / sponsor
- Sino-American Network for Therapeutic Radiology and Oncology
- Latest issue on the website
- Volume 10, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Precision Radiation Oncology
What CAS zone is Precision Radiation Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Precision Radiation Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Precision Radiation Oncology?
The journal's website gives an impact factor of 3.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.8, h-index 19.
How long does peer review take at Precision Radiation Oncology?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 129 days (interquartile range 79–183 days); authors report an average review time of about 13 weeks; the journal's website gives an acceptance rate of 30% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Precision Radiation Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Precision Radiation Oncology based?
Of the 211 board members whose country the journal's board page names, 175 (about 83%) are in mainland China; the countries named most often are Mainland China (175), United States (30) and Australia (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Precision Radiation Oncology?
According to LetPub and DOAJ records, Precision Radiation Oncology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, PMC and Embase; that list has not been checked against each database.
Is Precision Radiation Oncology open access, and what is the APC?
Precision Radiation Oncology is a fully open-access journal. APC about USD 2,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .